Intra-Cellular Therapies (ITCI) Cash US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Cash, bln rub | 224.0 | 657.4 | 412.3 | 591.9 | 497.9 | 477.4 | |||
Changes by years, y/y, % | -36% | +193% | -37% | +44% | -16% | +7.5% |
Intra-Cellular Therapies. Cash, bln rub
Intra-Cellular Therapies. Cash, changes, %
Intra-Cellular Therapies (ITCI) Cash US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
Cash, bln rub | 538.7 | 512.9 | 493.0 | 497.9 | 477.4 | 477.4 | ||
Changes by years, y/y, % | -30% | -24% | -22% | -16% | -11% | |||
Changes by quarters, q/q, % | -9% | -5% | -4% | +1% | -4% |